Eli Lilly & Co. (LLY) Falls as Bernie Sanders Questions Insulin Drug Price Increases

November 1, 2016 12:50 PM EDT

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Eli Lilly & Co. (NYSE: LLY) is lower after Bernie Sanders highlighted the surging cost of the company's insulin drug Humalog. Shares are down 1.8%.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

FDA, Trader Talk

Add Your Comment